Which has the lower trailing P/E, CI or REGN?

CI has the lower trailing P/E: CI trades at 12.34 and REGN at 16.26. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or REGN?

Over the past five years, CI grew revenue faster — CI at a 11.28% CAGR versus REGN at 10.16%.

Does CI or REGN pay a bigger dividend?

CI yields 2.11% and REGN yields 0.55% based on trailing dividends and the latest price.

Is CI or REGN more profitable?

REGN runs the higher net margin — CI at 2.26% versus REGN at 29.65%.

How have CI and REGN total returns compared?

Over the past 10 years, CI delivered 8.83% and REGN delivered 5.44% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Regeneron Pharmaceuticals, Inc. (REGN)

A side-by-side comparison of Cigna Corporation and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$79.64B

$301.06HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

REGN

Regeneron Pharmaceuticals, Inc.

$71.62B

$695.18HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — CI vs REGN

growth of $100 · dividends reinvested · last 30y

CI +3104.9%REGN +4131.1%REGN compounded faster

CI REGN

CI vs REGN: by the numbers

•CI is the larger company ($79.64B vs $71.62B market cap).
•CI trades at the lower trailing earnings multiple (12.34 vs 16.26 P/E), one valuation lens rather than an overall verdict.
•REGN converts more revenue to profit (29.65% vs 2.26% net margin).
•CI grew revenue faster over the past five years (11.28% vs 10.16% CAGR).
•CI pays the higher dividend yield (2.11% vs 0.55%).

Metrics side by side

Valuation

Metric	CI	REGN
P/E ratio	12.34	16.26
Forward P/E	9.55	14.58
P/S ratio	0.28	4.82
P/B ratio	1.82	2.29
PEG ratio	0.15	3.38
EV / EBITDA	8.31	17.17
FCF yield	9.96%	5.78%

Profitability

Metric	CI	REGN
Gross margin	9.30%	84.55%
Operating margin	3.42%	24.32%
Net margin	2.26%	29.65%
ROE	14.90%	14.08%
ROIC	7.35%	8.51%

Dividends

Metric	CI	REGN
Dividend yield	2.11%	0.55%
Payout ratio	27.53%	8.45%

Growth (annualized)

Metric	CI	REGN
Revenue CAGR (5Y)	11.28%	10.16%
EPS CAGR (5Y)	-0.76%	5.70%
FCF CAGR (5Y)	-2.03%	15.42%
Total return CAGR (5Y)	6.87%	3.56%

Frequently asked

Which has the lower trailing P/E, CI or REGN?: CI has the lower trailing P/E: CI trades at 12.34 and REGN at 16.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or REGN?: Over the past five years, CI grew revenue faster — CI at a 11.28% CAGR versus REGN at 10.16%.
Does CI or REGN pay a bigger dividend?: CI yields 2.11% and REGN yields 0.55% based on trailing dividends and the latest price.
Is CI or REGN more profitable?: REGN runs the higher net margin — CI at 2.26% versus REGN at 29.65%.
How have CI and REGN total returns compared?: Over the past 10 years, CI delivered 8.83% and REGN delivered 5.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Regeneron Pharmaceuticals P/E ratio Cigna dividend yield Regeneron Pharmaceuticals dividend yield Cigna ROE Regeneron Pharmaceuticals ROE Cigna operating margin Regeneron Pharmaceuticals operating margin Cigna revenue growth Regeneron Pharmaceuticals revenue growth Cigna free cash flow Regeneron Pharmaceuticals free cash flow

Cigna & Regeneron Pharmaceuticals appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.